MEDIROM updates July 2025 KPIs via Form 6-K

MEDIROM Healthcare Technologies Inc. furnished a Form 6-K to inform investors that it is issuing a press release with updated major key performance indicators (KPIs) for the month of July 2025.

Accepted by SEC EDGAR 08/20/2025 - 06:10 AM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

6-K

Rhea-AI Filing Summary

MEDIROM Healthcare Technologies Inc. furnished a Form 6-K to inform investors that it is issuing a press release with updated major key performance indicators (KPIs) for the month of July 2025. The press release, dated August 20, 2025, is attached as Exhibit 99.1.

The submission clarifies that the information in this report, including the exhibit, is furnished rather than filed and is not automatically incorporated by reference into other securities law filings unless specifically stated there.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does MEDIROM (MRM) disclose in this Form 6-K?

The company discloses that it is issuing a press release announcing its major key performance indicators (KPIs) updated for the month of July 2025, furnished as Exhibit 99.1.

Which period do the MEDIROM (MRM) KPIs in the press release cover?

The press release described in this Form 6-K provides updated major KPIs for the month of July 2025.

When is the MEDIROM (MRM) KPI press release dated?

The press release containing the major KPI update is dated August 20, 2025.

Is the information in this MEDIROM (MRM) Form 6-K considered filed with the SEC?

No. The company states that the information in this Form 6-K, including the exhibit, is furnished and not deemed filed for purposes of Section 18 of the Exchange Act.

Is the MEDIROM (MRM) KPI press release automatically incorporated into other SEC filings?

The company states that the information will not be incorporated by reference into other Securities Act or Exchange Act filings unless specifically provided in such a filing.

Who signed this MEDIROM (MRM) Form 6-K?

The report was signed on behalf of MEDIROM Healthcare Technologies Inc. by Fumitoshi Fujiwara, Chief Financial Officer, dated August 20, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August, 2025

Commission File Number 001-39809

MEDIROM HEALTHCARE TECHNOLOGIES INC.

(Translation of registrant’s name into English)

2-3-1 Daiba, Minato-ku

Tokyo 135-0091, Japan

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

☒ Form 20-F ☐ Form 40-F

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

Issuance of Press Release

On August 20, 2025, MEDIROM Healthcare Technologies Inc. (the “Company”) is issuing a press release announcing its major Key Performance Indicators, or KPIs, updated for the month of July 2025. A copy of the press release, dated August 20, 2025, is furnished as Exhibit 99.1 hereto.

The information furnished in this report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, as amended, except to the extent specifically provided in such a filing.

EXHIBIT INDEX


Exhibit No.		Description
99.1		Press release of the Company

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	MEDIROM HEALTHCARE TECHNOLOGIES INC.
Date: August 20, 2025
	By:	/s/ Fumitoshi Fujiwara
		Name: Fumitoshi Fujiwara
		Title: Chief Financial Officer

Source: View Original Filing on SEC EDGAR